The Expression of β-Microseminoprotein but Not CRISP3 Is Reduced in Ovarian Cancer and Correlates to Survival.

Rudi Henriksen, Åke Lundwall, Lene Udby, Per Fernlund

Research output: Contribution to journalArticlepeer-review

Abstract

β-Microseminoprotein (MSMB) is an abundant protein in seminal plasma. Most of it is present as a free protein but a small part is bound to cysteine-rich secretory protein 3 (CRISP3) as a non-covalent complex. Even though their physiological function is unknown, both MSMB and CRISP3 have been ascribed roles in prostate carcinogenesis. Thus, several recent experimental studies indicate a tumor-suppressor role for MSMB. The present study was undertaken in order to evaluate, for the first time, the expression of MSMB and CRISP3 in ovaries and in ovarian tumors and to determine if their expression might indicate a role in ovarian tumor development.
Original languageEnglish
Pages (from-to)3993-3999
JournalAnticancer research
Volume32
Issue number9
Publication statusPublished - 2012

Subject classification (UKÄ)

  • Cancer and Oncology

Free keywords

  • CRISP3
  • beta-Microseminoprotein
  • immunohistochemistry
  • ovary
  • ovarian
  • cancer
  • survival

Fingerprint

Dive into the research topics of 'The Expression of β-Microseminoprotein but Not CRISP3 Is Reduced in Ovarian Cancer and Correlates to Survival.'. Together they form a unique fingerprint.

Cite this